Aravive, Inc. (ARAV Quick QuoteARAV - Free Report) was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 134.7% in the past one-month time frame.

The company has seen two positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Aravive. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Aravive currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%. 

Aravive, Inc. Price

Investors interested in the Medical – Biomedical and Genetics industry may consider Abeona Therapeutics Inc. , which has a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
 
Today, See These 5 Potential Home Runs >>